Managing Cytokine Release Syndrome and Neurotoxicity with Step-Up Dosing of Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.07.151 ◽

2019 ◽

Vol 19 ◽

pp. S247

Author(s):

Nancy L. Bartlett ◽

Laurie H. Sehn ◽

Sarit Assouline ◽

Francesc Bosch ◽

Catherine M. Diefenbach ◽

...

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Cytokine Release ◽

Cytokine Release Syndrome ◽

Non Hodgkin Lymphoma

Download Full-text

The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma

Signal Transduction and Targeted Therapy ◽

10.1038/s41392-020-00256-x ◽

2020 ◽

Vol 5 (1) ◽

Author(s):

Jianshu Wei ◽

Yang Liu ◽

Chunmeng Wang ◽

Yajing Zhang ◽

Chuan Tong ◽

...

Keyword(s):

T Cell ◽

B Cell ◽

Hodgkin Lymphoma ◽

Cytokine Release ◽

Cytokine Release Syndrome ◽

Non Hodgkin Lymphoma ◽

Download Full-text

PS1094 MANAGING CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY WITH STEP-FRACTIONATED DOSING OF MOSUNETUZUMAB IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (NHL)

10.1097/01.hs9.0000562668.33884.40 ◽

2019 ◽

Vol 3 (S1) ◽

pp. 496

Author(s):

S.-S. Yoon ◽

M. Matasar ◽

L.H. Sehn ◽

S. Assouline ◽

N.L. Bartlett ◽

...

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Cytokine Release ◽

Cytokine Release Syndrome ◽

Non Hodgkin Lymphoma

Download Full-text

MANAGING CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY WITH STEP-UP DOSING OF MOSUNETUZUMAB IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (NHL)

Hematological Oncology ◽

10.1002/hon.119_2630 ◽

2019 ◽

Vol 37 ◽

pp. 310-311

Author(s):

L.H. Sehn ◽

S. Assouline ◽

N.L. Bartlett ◽

F. Bosch ◽

C.M. Diefenbach ◽

...

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Cytokine Release ◽

Cytokine Release Syndrome ◽

Non Hodgkin Lymphoma

Download Full-text

Individual Patient Data Meta-Analysis from 16 Trials for Safety Factors in Cytokine Release Syndrome After CAR-T Therapy in Patients with Non-Hodgkin Lymphoma (NHL) and Acute Lymphoblastic Leukemia

Advances in Therapy ◽

10.1007/s12325-019-01056-8 ◽

2019 ◽

Vol 36 (10) ◽

pp. 2881-2894 ◽

Author(s):

Jie Li ◽

Zhenyu Wu ◽

Naiqing Zhao

Keyword(s):

Acute Lymphoblastic Leukemia ◽

Hodgkin Lymphoma ◽

Individual Patient Data ◽

Lymphoblastic Leukemia ◽

Meta Analysis ◽

Cytokine Release ◽

Cytokine Release Syndrome ◽

Safety Factors ◽

Non Hodgkin Lymphoma ◽

Download Full-text

PCN241 COSTS OF CYTOKINE RELEASE SYNDROME (CRS) AND NEUROLOGICAL EVENTS (NE) IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA RECEIVING LISOCABTAGENE MARALEUCEL (LISO-CEL) IN THE TRANSCEND NHL 001 CLINICAL TRIAL: A MICRO-COSTING STUDY FROM THE SPANISH NATIONAL HEALTH SYSTEM (NHS) PERSPECTIVE

Value in Health ◽

10.1016/j.jval.2019.09.436 ◽

2019 ◽

Vol 22 ◽

pp. S482

Author(s):

M. Presa ◽

C. Varela ◽

I. Oyagüez

Keyword(s):

Clinical Trial ◽

Health System ◽

Hodgkin Lymphoma ◽

National Health ◽

National Health System ◽

Cytokine Release ◽

Cytokine Release Syndrome ◽

Non Hodgkin Lymphoma ◽

Spanish National Health System ◽

Download Full-text

B-cell non-Hodgkin lymphoma (B-NHL) in patients with chronic hepatitis C. A report of 5 cases

Zeitschrift für Gastroenterologie ◽

10.1055/s-0033-1347495 ◽

2013 ◽

Vol 51 (05) ◽

Author(s):

I Nagy ◽

A Pálvölgyi ◽

S Modok ◽

T Wittmann

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

B Cell ◽

Hodgkin Lymphoma ◽

Chronic Hepatitis C ◽

Non Hodgkin Lymphoma

Download Full-text

B-Cell Non-Hodgkin Lymphoma

10.32388/91hm87 ◽

2020 ◽

Author(s):

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Non Hodgkin Lymphoma

Download Full-text

Anti-Lipopolysaccharide Antibodies and Osmotic Resistance of Erythrocytes in Healthy Individuals and Patients with B-Cell Non-Hodgkin Lymphoma with Different Blood Groups

Mikrobiolohichnyi Zhurnal ◽

10.15407/microbiolj82.04.003 ◽

2020 ◽

Vol 82 (4) ◽

pp. 3-12

Author(s):

L.D. Varbanets ◽

◽

K.G. Garkava ◽

O.S. Brovarskaya ◽

T.V. Bulyhina ◽

...

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Blood Groups ◽

Osmotic Resistance ◽

Healthy Individuals ◽

Non Hodgkin Lymphoma ◽

Osmotic Resistance Of Erythrocytes

Download Full-text

Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.

Case Medical Research ◽

10.31525/ct1-nct03886649 ◽

2019 ◽

Author(s):

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Non Hodgkin Lymphoma

Download Full-text

Acalabrutinib With Rituximab and Lenalidomide in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Case Medical Research ◽

10.31525/ct1-nct04094142 ◽

2019 ◽

Author(s):

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Non Hodgkin Lymphoma

Download Full-text